0001179110-20-003226.txt : 20200306
0001179110-20-003226.hdr.sgml : 20200306
20200306161010
ACCESSION NUMBER: 0001179110-20-003226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levy Lewis
CENTRAL INDEX KEY: 0001726568
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20694865
MAIL ADDRESS:
STREET 1: C/O TELADOC, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-05
0
0001477449
Teladoc Health, Inc.
TDOC
0001726568
Levy Lewis
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Medical Officer
Common Stock
2020-03-05
4
M
0
3207
A
9569
D
Common Stock
2020-03-05
4
F
0
1398
132.73
D
8171
D
Common Stock
2020-03-05
4
M
0
2467
A
10638
D
Common Stock
2020-03-05
4
F
0
711
132.73
D
9927
D
Common Stock
2020-03-05
4
S
0
1982
126.51
D
7945
D
Performance Stock Units
2020-03-05
4
M
0
3207
0.00
D
Common Stock
3207
6416
D
Restricted Stock Units
2020-03-05
4
M
0
2467
0.00
D
Common Stock
2467
4935
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
On February 26, 2020, the reporting person earned 9,623 performance stock units, vesting in three annual installments beginning on March 4, 2020.
On March 4, 2019, the reporting person was granted 7,402 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019.
/s/ Adam C. Vandervoort, attorney-in-fact
2020-03-06